-
Register Now
-
Registration for this event is currently not available. For more information, please email support or call the Special Services number listed below.
Special Services
If you require special assistance to attend this event, please contact Stephanie.Gaiser@uky.edu.

Accreditation Information
In support of improving patient care, University of Kentucky HealthCare CECentral is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
CME
This live activity is designated for a maximum of 3.25 AMA PRA Category 1 Credit(s)™. Physicians should claim only credit commensurate with the extent of their participation in the activity.
Other
UK Healthcare CECentral certifies this activity for 3.25 hours of participation.
CNE
The maximum number of hours awarded for this Continuing Nursing Education activity is 3.25 nursing contact hours.
AMA PRA Category 1 CME for ABS MOC II (Surgery)
This live activity is designated for a maximum of 3.25 AMA PRA Category 1 Credit(s)™. Physicians should claim only credit commensurate with the extent of their participation in the activity. Successful completion of this CME activity, which includes participation in the evaluation component, enables the learner to earn credit toward the CME of the American Board of Surgery's Continuous Certification program. It is UK HealthCare CECentral's responsibility to submit learner completion information to ACCME for the purpose of granting ABS credit. Surgeons completing this course receive 3.25 continuing education credits
Needs Statement
2024 2024 Rapidly evolving new tests incorporating case-based approach and incorporate these tests into diagnosis and treatment decisions for BPH and HoLEP. Development of new technologies and how to apply these technologies within current management guidelines.
Objectives
Upon completion of this activity, learners will be able to:
-
Describe which areas of reconstructive urology are addressed within the current AUA guidelines for the management of reconstruction-related diseases.
-
Explain the evolving role of the case-based approach in managing reconstructive urology diseases and discuss how new technologies may influence this approach.
Target Audience
The target audience for this program includes physicians and mid-level providers.